Activities at the FHNW

Lableader 3D bioprinting and biohybrid microsystems

Research

The vision the 3D Bioprinting Group is to build cell-based biohybrid systems aimed for organs-on-chips as well as for implants aimed to enable personalized therapies/drugs and promote preventive healthcare respectively.  With this goal in mind, the 3D Bioprinting Group was able to strengthen and prove its competences in the following fields:

3D Bioprinting

• Bioprinting of vascularized and innervated thick tissues.
• Toxicological assays (body on chip, 3R Animal Free Research).
• Cell and extracellular matrix based functional micro implants.
• Cell-laden hydrogels, single and multicellular.
• Bioinert support materials.
• Ceramics for dental implants.
• Modelling, simulation and validation of 3D printing processes.

Biohybrid Microsystems

• Cell based micro robotics.
  
• Bioengineered neuromuscular junctions.